Furthermore, FRα is more prevalent in adenocarcinomas than in squamous-cell lung cancers, underscoring its potential as a promising tool in ctDNA research for diagnosis, prognosis, treatment, and therapy-response monitoring [62]. Here, FOLR1 is linked to adenocarcinoma.